Human Genome Epidemiology Literature Finder
Records 1 - 6 (of 6 Records) |
Query Trace: Neoplasms and meta-analysis and DPYD[original query] |
---|
Genetic markers of toxicity from capecitabine and other fluorouracil-based regimens: investigation in the QUASAR2 study, systematic review, and meta-analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2014 Apr 32 (10): 1031-9. Rosmarin Dan, Palles Claire, Church David, Domingo Enric, Jones Angela, Johnstone Elaine, Wang Haitao, Love Sharon, Julier Patrick, Scudder Claire, Nicholson George, Gonzalez-Neira Anna, Martin Miguel, Sargent Daniel, Green Erin, McLeod Howard, Zanger Ulrich M, Schwab Matthias, Braun Michael, Seymour Matthew, Thompson Lindsay, Lacas Benjamin, Boige Valérie, Ribelles Nuria, Afzal Shoaib, Enghusen Henrik, Jensen Søren Astrup, Etienne-Grimaldi Marie-Christine, Milano Gérard, Wadelius Mia, Glimelius Bengt, Garmo Hans, Gusella Milena, Lecomte Thierry, Laurent-Puig Pierre, Martinez-Balibrea Eva, Sharma Rohini, Garcia-Foncillas Jesus, Kleibl Zdenek, Morel Alain, Pignon Jean-Pierre, Midgley Rachel, Kerr David, Tomlinson I |
Association and prediction of severe 5-fluorouracil toxicity with dihydropyrimidine dehydrogenase gene polymorphisms: A meta-analysis. Biomedical reports 2015 Nov 3 (6): 879-883. Leung Henry W C, Chan Agnes L |
Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data. The Lancet. Oncology 2015 Oct . Meulendijks Didier, Henricks Linda M, Sonke Gabe S, Deenen Maarten J, Froehlich Tanja K, Amstutz Ursula, Largiadèr Carlo R, Jennings Barbara A, Marinaki Anthony M, Sanderson Jeremy D, Kleibl Zdenek, Kleiblova Petra, Schwab Matthias, Zanger Ulrich M, Palles Claire, Tomlinson Ian, Gross Eva, van Kuilenburg André B P, Punt Cornelis J A, Koopman Miriam, Beijnen Jos H, Cats Annemieke, Schellens Jan H |
Influence of DPYD Genetic Polymorphisms on 5-Fluorouracil Toxicities in Patients with Colorectal Cancer: A Meta-Analysis. Gastroenterology research and practice 2014 2014 827989. Li Qiang, Liu Ying, Zhang Hong-Mei, Huang Yin-Peng, Wang Tian-Yi, Li Dong-Sheng, Sun Hong-Z |
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis. The Lancet. Oncology 2018 10 19 (11): 1459-1467. Henricks Linda M, Lunenburg Carin A T C, de Man Femke M, Meulendijks Didier, Frederix Geert W J, Kienhuis Emma, Creemers Geert-Jan, Baars Arnold, Dezentjé Vincent O, Imholz Alexander L T, Jeurissen Frank J F, Portielje Johanna E A, Jansen Rob L H, Hamberg Paul, Ten Tije Albert J, Droogendijk Helga J, Koopman Miriam, Nieboer Peter, van de Poel Marlène H W, Mandigers Caroline M P W, Rosing Hilde, Beijnen Jos H, Werkhoven Erik van, van Kuilenburg André B P, van Schaik Ron H N, Mathijssen Ron H J, Swen Jesse J, Gelderblom Hans, Cats Annemieke, Guchelaar Henk-Jan, Schellens Jan H |
Retracted: Influence of DPYD Genetic Polymorphisms on 5-Fluorouracil Toxicities in Patients with Colorectal Cancer: A Meta-Analysis. Gastroenterology research and practice 2020 2020 9470819. Research And Practice Gastroenterolo |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: